171 related articles for article (PubMed ID: 19630384)
1. Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.
Lainé DI; Wan Z; Yan H; Zhu C; Xie H; Fu W; Busch-Petersen J; Neipp C; Davis R; Widdowson KL; Blaney FE; Foley J; Bacon AM; Webb EF; Luttmann MA; Burman M; Sarau HM; Salmon M; Palovich MR; Belmonte K
J Med Chem; 2009 Aug; 52(16):5241-52. PubMed ID: 19630384
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.
Lainé DI; Xie H; Buffet N; Foley JJ; Buckley P; Webb EF; Widdowson KL; Palovich MR; Belmonte KE
Bioorg Med Chem Lett; 2007 Nov; 17(22):6066-9. PubMed ID: 17911022
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.
Lainé DI; McCleland B; Thomas S; Neipp C; Underwood B; Dufour J; Widdowson KL; Palovich MR; Blaney FE; Foley JJ; Webb EF; Luttmann MA; Burman M; Belmonte K; Salmon M
J Med Chem; 2009 Apr; 52(8):2493-505. PubMed ID: 19317446
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).
Prat M; Fernández D; Buil MA; Crespo MI; Casals G; Ferrer M; Tort L; Castro J; Monleón JM; Gavaldà A; Miralpeix M; Ramos I; Doménech T; Vilella D; Antón F; Huerta JM; Espinosa S; López M; Sentellas S; González M; Albertí J; Segarra V; Cárdenas A; Beleta J; Ryder H
J Med Chem; 2009 Aug; 52(16):5076-92. PubMed ID: 19653626
[TBL] [Abstract][Full Text] [Related]
5. Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.
Wan Z; Laine DI; Yan H; Zhu C; Widdowson KL; Buckley PT; Burman M; Foley JJ; Sarau HM; Schmidt DB; Webb EF; Belmonte KE; Palovich M
Bioorg Med Chem Lett; 2009 Aug; 19(16):4560-2. PubMed ID: 19616944
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.
Lainé DI; Yan H; Xie H; Davis RS; Dufour J; Widdowson KL; Palovich MR; Wan Z; Foley JJ; Schmidt DB; Hunsberger GE; Burman M; Bacon AM; Webb EF; Luttmann MA; Salmon M; Sarau HM; Umbrecht ST; Landis PS; Peck BJ; Busch-Petersen J
Bioorg Med Chem Lett; 2012 May; 22(9):3366-9. PubMed ID: 22460029
[TBL] [Abstract][Full Text] [Related]
7. Bronchodilator activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a potent, long-acting, and selective muscarinic M3 receptor antagonist.
Villetti G; Pastore F; Bergamaschi M; Bassani F; Bolzoni PT; Battipaglia L; Amari G; Rizzi A; Delcanale M; Volta R; Cenacchi V; Cacciani F; Zaniboni M; Berti F; Rossoni G; Harrison S; Petrillo P; Santoro E; Scudellaro R; Mannini F; Geppetti PA; Razzetti R; Patacchini R; Civelli M
J Pharmacol Exp Ther; 2010 Dec; 335(3):622-35. PubMed ID: 20805306
[TBL] [Abstract][Full Text] [Related]
8. Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).
Peretto I; Fossati C; Giardina GA; Giardini A; Guala M; La Porta E; Petrillo P; Radaelli S; Radice L; Raveglia LF; Santoro E; Scudellaro R; Scarpitta F; Cerri A; Menegon S; Dondio GM; Rizzi A; Armani E; Amari G; Civelli M; Villetti G; Patacchini R; Bergamaschi M; Bassani F; Delcanale M; Imbimbo BP
J Med Chem; 2007 Apr; 50(7):1693-7. PubMed ID: 17352463
[TBL] [Abstract][Full Text] [Related]
9. Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).
Peretto I; Forlani R; Fossati C; Giardina GA; Giardini A; Guala M; La Porta E; Petrillo P; Radaelli S; Radice L; Raveglia LF; Santoro E; Scudellaro R; Scarpitta F; Bigogno C; Misiano P; Dondio GM; Rizzi A; Armani E; Amari G; Civelli M; Villetti G; Patacchini R; Bergamaschi M; Delcanale M; Salcedo C; Fernández AG; Imbimbo BP
J Med Chem; 2007 Apr; 50(7):1571-83. PubMed ID: 17352462
[TBL] [Abstract][Full Text] [Related]
10. The effect of absolute configuration on activity, subtype selectivity (M3/M2) of 3α-acyloxy-6β-acetoxyltropane derivatives as muscarinic M3 receptor antagonists.
Wang ZP; Liu HZ; Zhu L; Hu YM; Cui YY; Niu YY; Lu Y; Chen HZ
Bioorg Med Chem; 2013 Mar; 21(5):1234-9. PubMed ID: 23375092
[TBL] [Abstract][Full Text] [Related]
11. M3/M1-Selective antimuscarinic tropinyl and piperidinyl esters.
Xu R; Sim MK; Go ML
Eur J Pharm Sci; 1999 Apr; 8(1):39-47. PubMed ID: 10072477
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure.
Dei S; Bellucci C; Buccioni M; Ferraroni M; Guandalini L; Manetti D; Martini E; Marucci G; Matucci R; Nesi M; Romanelli MN; Scapecchi S; Teodori E
J Med Chem; 2007 Mar; 50(6):1409-13. PubMed ID: 17305327
[TBL] [Abstract][Full Text] [Related]
13. C(8) substituted 1-azabicyclo[3.3.1]non-3-enes and C(8) substituted 1-azabicyclo[3.3.1]nonan-4-ones: novel muscarinic receptor antagonists.
Kim MG; Bodor ET; Wang C; Harden TK; Kohn H
J Med Chem; 2003 May; 46(11):2216-26. PubMed ID: 12747793
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists.
Naito R; Yonetoku Y; Okamoto Y; Toyoshima A; Ikeda K; Takeuchi M
J Med Chem; 2005 Oct; 48(21):6597-606. PubMed ID: 16220976
[TBL] [Abstract][Full Text] [Related]
15. Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists.
Bolognesi ML; Minarini A; Budriesi R; Cacciaguerra S; Chiarini A; Spampinato S; Tumiatti V; Melchiorre C
J Med Chem; 1998 Oct; 41(21):4150-60. PubMed ID: 9767650
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases.
Salmon M; Luttmann MA; Foley JJ; Buckley PT; Schmidt DB; Burman M; Webb EF; DeHaas CJ; Kotzer CJ; Barrett VJ; Slack RJ; Sarau HM; Palovich MR; Lainé DI; Hay DW; Rumsey WL
J Pharmacol Exp Ther; 2013 May; 345(2):260-70. PubMed ID: 23435542
[TBL] [Abstract][Full Text] [Related]
17. Selective muscarinic antagonists. II. Synthesis and antimuscarinic properties of biphenylylcarbamate derivatives.
Naito R; Takeuchi M; Morihira K; Hayakawa M; Ikeda K; Shibanuma T; Isomura Y
Chem Pharm Bull (Tokyo); 1998 Aug; 46(8):1286-94. PubMed ID: 9734316
[TBL] [Abstract][Full Text] [Related]
18. Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile.
Gavaldà A; Miralpeix M; Ramos I; Otal R; Carreño C; Viñals M; Doménech T; Carcasona C; Reyes B; Vilella D; Gras J; Cortijo J; Morcillo E; Llenas J; Ryder H; Beleta J
J Pharmacol Exp Ther; 2009 Nov; 331(2):740-51. PubMed ID: 19710368
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antagonistic activity at muscarinic receptor subtypes of some derivatives of diphenidol.
Varoli L; Angeli P; Buccioni M; Burnelli S; Cavalli A; Marucci G; Recanatini M
Farmaco; 2003 Sep; 58(9):651-7. PubMed ID: 13679157
[TBL] [Abstract][Full Text] [Related]
20. Functional roles of muscarinic M2 and M3 receptors in mouse stomach motility: studies with muscarinic receptor knockout mice.
Kitazawa T; Hashiba K; Cao J; Unno T; Komori S; Yamada M; Wess J; Taneike T
Eur J Pharmacol; 2007 Jan; 554(2-3):212-22. PubMed ID: 17113073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
